Journals / Viral Hepatitis Journal / 2021 / Cilt: 27 - Sayı: 2

Results of Viral Hepatitis and Human Immunodeficiency Virus Screening in Afghan Irregular Migrants: A Crosssectional Study (2011-2019)

Afgan Düzensiz Göçmenlerin Viral Hepatit ve İnsan Bağışıklık Yetersizliği VirüsüEnfeksiyonu Tarama Sonuçları: Kesitsel Çalışma (2011-2019)

Pages
98–102
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As there is limited information pertaining to these groups in the literature, having access to health data will be beneficial for physicians who provide medical care to this group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of the study was to present human immunodeficiency virus (HIV) and hepatitis A, B, and C seroprevalence data in Afghan irregular migrants.
📊
Key Findings & Data:Materials and Methods: This retrospective cross-sectional study was conducted in Erzurum, which had two of Turkey’s 28 immigration removal centers, and included 9,197 Afghan irregular migrants of all ages referred to the hospital between January 2011- 2019.
💡
Conclusion & Impact:As there is limited information pertaining to these groups in the literature, having access to health data will be beneficial for physicians who provide medical care to this group.
🔬Design:Research Article
📍Scope:2011- 2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of the study was to present human immunodeficiency virus (HIV) and hepatitis A, B, and C seroprevalence data in Afghan irregular migrants. Materials and Methods: This retrospective cross-sectional study was conducted in Erzurum, which had two of Turkey’s 28 immigration removal centers, and included 9,197 Afghan irregular migrants of all ages referred to the hospital between January 2011- 2019. Continuous data were presented as median (minimummaximum) values; categorical variables were expressed as frequency (percentage) values. Results: Seropositivity rates were 5.5% for hepatitis B surface antigen (HBsAg), 1.6% for hepatitis C virus, 94.3% for hepatitis A virus (HAV), and 0.2% for HIV. Rates of HBsAg, anti-hepatitis B core antibody immunoglobulin G (anti-HBc IgG), and anti-HAV positivities were significantly lower in the 0-15 age group, while the rate of anti-HBs positivity was significantly higher in the 0-15 and ≥41 age groups. In the 7,196 immigrants who underwent all three hepatitis B tests (HBsAg, anti-HBs, and anti-HBc IgG), infection was detected in 7.0%, while 87.5% had never encountered hepatitis B or been vaccinated against hepatitis B. Conclusion: Epidemiological studies on migrant populations are necessary to protect public health in the host country. As there is limited information pertaining to these groups in the literature, having access to health data will be beneficial for physicians who provide medical care to this group.

Özet

Amaç: Afgan düzensiz göçmenlerin hepatit A, B, C ve insan bağışıklık yetmezliği virüsü (HIV) enfeksiyonu seroprevalanslarının sunulması amaçlanmıştır. Gereç ve Yöntemler: Bu retrospektif kesitsel çalışma, ülkede bulunan 28 geri gönderme merkezinden ikisine sahip olan Erzurum ilinde yürütüldü ve çalışmaya Ocak 2011-2019 tarihleri arasında hastaneye sevk edilen tüm yaşlardan 9.197 Afgan düzensiz göçmen dahil edildi. Sürekli veriler ortanca (en küçük-en büyük), kategorik değişkenler frekans (yüzde) olarak sunuldu. Bulgular: Hepatit B yüzey antijeni (HBsAg) seropozitifliği %5,5; hepatit C virüs seropozitifliği %1,6; hepatit A virüs (HAV) seropozitifliği %94,3 ve HIV seropozitifliği %0,2 olarak tespit edildi. HBsAg, anti-hepatit B çekirdek antikoru immünoglobulin G (anti-HBc IgG) ve anti-HAV pozitiflik sıklığı 0-15 yaş grubunda anlamlı olarak daha düşük; anti-HBs pozitiflik sıklığı 0-15 ve ≥41 yaş gruplarında anlamlı olarak daha yüksek bulundu. Hepatit B (HBsAg, anti-HBs ve anti-HBc IgG) testlerinin her üçünün de yapıldığı 7.196 göçmende ise hepatit B enfeksiyonu %7,0 sıklıkta bulunurken, göçmenlerin %87,5’inin hepatit B ile karşılamadıkları ve/veya hepatit B’ye karşı aşılanmadıkları görülmüştür. Sonuç: Göçmen nüfus, ev sahibi ülkede toplum sağlığı için epidemiyolojik incelemeler gerektiren bir gruptur. Literatürde bu gruplar ile ilgili verilerin sınırlı olduğu da göz önüne alındığında özellikle bu gruba tıbbi bakım sağlayan hekimlerin sağlık verilerine sahip olması faydalı olacaktır

🔖

Cite This Article

KARAŞAHİN, E. F., KALKAN, İ. A., KARAŞAHİN, Ö. (2022). Results of Viral Hepatitis and Human Immunodeficiency Virus Screening in Afghan Irregular Migrants: A Crosssectional Study (2011-2019). Viral Hepatitis Journal, Cilt: 27 - Sayı: 2, 98–102. https://ajindex.com/articles/646319

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. World Health Organization. Global Strategy for Women’s, Children’s and Adolescents’ Health (2016-2030) 2018. [accessed May 2020].
  2. Republic of Turkey Ministry of Interior Directorate Generalof Migration Managment. Irregular Migration 2020. [accessed May 2020].
  3. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370-398
  4. Todd CS, Nasir A, Mansoor GF, Sahibzada SM, Jagodzinski LL, Salimi F, Khateri MN, Hale BR, Barthel RV, Scott PT. Crosssectional assessment of prevalence and correlates of blood-borne and sexually-transmitted infections among Afghan National Army recruits. BMC Infect Dis 2012;12:196
  5. Central Blood Bank: Report of Testing of Blood Donors from March-December, 2006. Ministry of Public Health; 2006
  6. World Health Organization. World Health Organization in Afghanistan 2019. [accessed May 2020] http://www.emro.who. int/images/stories/afghanistan/who_at_a_glance_2019_feb. pdf?ua=1 7. World Health Organization. Global Health Observatory country views 2015. [accessed May 2020]. https://apps.who.int/gho/data/ node.country.country-AFG 8. World Health Organization. 2019 Fact sheets/Hepatitis B. [accessed May 2020]. https://www.who.int/news-room/factsheets/detail/hepatitis-b#:~:text=Key%20facts,blood%20or%20 other%20body%20fluids 9. World Health Organization. Fact Sheets/Hepatitis C 2019. [accessed May 2020] https://www.who.int/news-room/factsheets/detail/hepatitis-c#:~:text=Key%20facts,major%20 cause%20of%20liver%20cancer.W 10. World Health Organization. Fact Sheet/HIV-AIDS 2019. [accessed May 2020] https://www.who.int/news-room/fact-sheets/detail/ hiv-aids 11. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, Earhart KC. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 2007;13:1327-1331
  7. Rein DB, Lesesne SB, O’Fallon A, Weinbaum CM. Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008. Hepatology 2010;51:431-434
  8. Centers for Disease Control CDC. Screening for hepatitis B virus infection among refugees arriving in the United States, 1979- 1991. MMWR Morb Mortal Wkly Rep 1991;40:784-786
  9. Khan S, Attaullah S. Share of Afghanistan populace in hepatitis B and hepatitis C infection’s pool: is it